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Interactions between enamel matrix proteins are important for enamel biomineralization. In recent
in situ studies, we showed that the N-terminal proteolytic product of ameloblastin co-localized with
amelogenin around the prism boundaries. However, the molecular mechanisms of such interactions are
still unclear. Here, in order to determine the interacting domains between amelogenin and ameloblastin,
we designed four ameloblastin peptides derived from different regions of the full-length protein (AB1,
AB2 and AB3 at N-terminus, and AB6 at C-terminus) and studied their interactions with recombinant
amelogenin (rP172), and the tyrosine-rich amelogenin polypeptide (TRAP). A series of amelogenin Trp
variants (rP172(W25), rP172(W45) and rP172(W161)) were also used for intrinsic ﬂuorescence spec-
troscopy. Fluorescence spectra of rP172 titrated with AB3, a peptide encoded by exon 5 of ameloblastin,
showed a shift in λmax in a dose-dependent manner, indicating molecular interactions in the region
encoded by exon 5 of ameloblastin. Circular dichroism (CD) spectra of amelogenin titrated with AB3
showed that amelogenin was responsible for forming α-helix in the presence of ameloblastin. Fluores-
cence spectra of amelogenin Trp variants as well as the spectra of TRAP titrated with AB3 showed that
the N-terminus of amelogenin is involved in the interaction between ameloblastin and amelogenin. We
suggest that macromolecular co-assembly between amelogenin and ameloblastin may play important
roles in enamel biomineralization.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The highly ordered structure of tooth enamel is regulated by
the cells and extracellular matrix proteins that work together to
control crystal initiation and organized growth [1]. These enamel
matrix proteins are secreted by ameloblasts during the secretory
stage of amelogenesis to create a mineralization front where the
enamel crystals grow in length. The matrix proteins are degraded
during the maturation stage by proteinases, and eventually re-
moved as the enamel crystals grow in width and thickness [2,3].
The major structural proteins in enamel are amelogenin (Amel),
ameloblastin (Ambn), amelotin (Amtn) and enamelin (Enam) [1].
Amelogenin is the most abundant, accounting for approximately
90% of the enamel matrix protein. Mutations in the amelogenin
gene result in X-linked amelogenesis imperfecta [4,5]. In 16-week-
old mice, amelogenin deﬁciency resulted in an enamel thickness
of o10% of normal enamel, with disorganized prism structure [6].B.V. This is an open access article u
lastin; TRAP, Tyrosine Rich
LC, High Performance Liquid
k).Ameloblastin is the second most abundant protein, accounting for
roughly 5% of enamel matrix protein [7]. Genomic deletion of
AMBN exon 6 in humans results in hypoplastic amelogenesis im-
perfecta [8]. In the Ambnmutant mouse that expressed a truncated
Ambn variant without the segment encoded by exons 5 and 6,
ameloblasts detached from the tooth surface at the early secretory
stage, and the mutation resulted in defective enamel formation
[9,10]. In vitro experiment further showed that the segment en-
coded by exon 5 may be involved in ameloblastin self-
assembly [11].
Evidence for the notion that amelogenin and ameloblastin may
have cooperative function was provided by recent double knock
out animal model studies [10]. In 7-day-old Amel X-/-/Ambn-/- mice,
the ameloblast layer was irregular and detached from the enamel
surface as in Ambn-/- mice, and the enamel width was signiﬁcantly
thinner than that in Amel X-/- or Ambn-/- mice [12]. In a different
report, dual-immunogold labeling showed the co-distribution of
ameloblastin and amelogenin, suggesting a functional association
between these two proteins [13]. It has been shown that the
amelogenin trityrosyl-motif peptide localized at the N-terminal
region of amelogenin binds to ameloblastin [14]. Immunochemical
assays revealed that ameloblastin co-localized with amelogenin
during the early stages of tooth development [15].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
The tryptophan residues of wild type amelogenin and its variants.
Name Location of Tryptophan residues
rP172 W25 W45 W161
rP172(W25) W25
rP172(W45) W45
rp172(W161) W161
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we reported that amelogenin co-localized with ameloblastin at the
mineralization front during the secretory stage of enamel forma-
tion [16]. We further demonstrated in vitro that addition of re-
combinant full-length amelogenin to recombinant full-length
ameloblastin induced conformational change in the latter, hinting
at intermolecular interactions between the two proteins [16]. Our
recent in vivo study further shows that the N-terminal proteolytic
product of ameloblastin co-localizes with the N-terminus of
amelogenin around the prism boundary [17]. However, it is not
known how these proteins interact and whether any structural
changes result from the interaction. In order to provide additional
support for direct amelogenin-ameloblastin interactions and to
determine the interacting domains between them, we designed
four ameloblastin peptides derived from different regions of the
full-length protein. We used intrinsic ﬂuorescence spectroscopy
and circular dichroism to study their interaction with amelogenin
and the N-terminal tyrosine-rich amelogenin polypeptide
(TRAP) [18].2. Materials and methods
2.1. Wild type and variant Amelogenin expression and puriﬁcation
Wild type (rP172) and variant recombinant porcine amelogenin
proteins were expressed in E. coli strain BL21(DE3)pLysS (Strata-
gene, CA), and precipitated by 20% ammonium sulfate following
the method described previously [19,20]. The ammonium sulfate
precipitate was dissolved in water containing 0.1% TFA and pur-
iﬁed using a high performance liquid chromatography (HPLC)
system (Varian, CA) equipped with a Phenomenex C4 column
(10250 mm, 5 mm). The puriﬁed proteins were lyophilized, kept
at 20 °C, and dissolved in water before use. Our group designed
three double-variant strains of amelogenin; rP172(W45Y, W161Y)
will be referred to as rP172(W25), rP172(W25Y, W161Y) will be
referred to as rP172(W45), and rP172(W25Y, W45Y) will be re-
ferred to as rP172(W161) [21]. The positions of tryptophan re-
sidues of rP172 and its variants are illustrated in Table 1.
2.2. Peptide synthesis
Four peptides (AB1, AB2, AB3, and AB6) were designed based
on the amino acid sequence of mouse ameloblastin (Ambn), and
synthesized by Chempeptide Limited (Shanghai, China). AB1 in-
cludes 40 amino acid residues encoded by exon 3 and 4, AB2 is
next to AB1 and includes 37 amino acid residues encoded by exon
5, AB3 is a variant of AB2 with two tryptophan residues sub-
stituted by two tyrosine residues, and AB6 includes 44 amino acid
residues encoded by exon 13 and located at the C-terminus of
Ambn. AB3 has no tryptophan residue, which is a ﬂuorophore, and
it is used instead of AB2 in the experiments where amelogenin-
ameloblastin interactions are studied. The purity of peptides was
determined by HPLC equipped with Kromasil-C18 column
(4.6250 mm, 5 mm), and the concentration was determined by
Pierce BCA protein assay kit (Thermo Scientiﬁc, IL).
TRAP consisting of 45 amino acid residues at the N-terminus of
full-length mouse amelogenin was synthesized at USC Micro-
chemical Core Facility as previously described [22]. The amino acid
sequences of AB1, AB2, AB3, AB6, and TRAP are shown in Table 2.
The two substituted tyrosine residues are labeled in red.
2.3. Intrinsic ﬂuorescence spectroscopy
Lyophilized amelogenin and peptides were ﬁrst dissolved in
water to make stock solutions with higher concentration ofprotein or peptide. All the samples were prepared by diluting the
protein or the peptide into buffer (5 mM Tris-HCl) at pH of 7.3.
Table 2 summarizes the molecular masses of the synthetic
peptides.
To investigate whether amelogenin interacts with ameloblastin,
samples containing 10 μM rP172 and 0, 5, 10, or 15 μM AB1, 10 μM
rP172 and 0, 5, 10, or 15 μM AB3, and 10 μM rP172 and 0, 5, 10, or
15 μM AB6 were prepared separately. For collecting ﬂuorescence
spectra of rP172 titrated with AB3, 10 μM rP172(W25) was mixed
with 0, 5, 10, or 15 μM AB3, 10 μM rP172(W45) was mixed with 0,
5, 10, or 15 μM AB3, and 10 rP172(W161) was mixed with 0, 5, 10,
or 15 μM AB3. For collecting ﬂuorescence spectra of TRAP titrated
with AB3, 10 μM TRAP was mixed with 0, 1, 5, or 10 μM AB3. After
preparation, all samples were kept at room temperature for 1 h
before measurement.
The ﬂuorescence emission spectra were collected using a
QuantaMaster 4 spectroﬂuorometer (Photon Technology Interna-
tional, NJ) equipped with a 1-cm path-length cuvette. The excita-
tion wavelength was 295 nm, the window sizes of the excitation
and the emission shutters were set to 5 nm, and the ﬁnal spectra
were the average of three scans. All ﬂuorescence experiments
were carried out at room temperature.
2.4. Circular dichroism (CD) spectroscopy
We mixed 2.5 μM of rP172 with 0, 1.25, 2.5 or 3.75 μM AB3
separately, and kept the solutions at room temperature for 1 h
before measurement. The ﬁnal solutions contained 5 mM Tris-HCl
and their pH was 7.3. The CD spectra were collected using a J-815
spectrometer (Jasco, Japan) with a 1-mm path-length cuvette. The
low concentration of Tris–HCl and short path-length reduced the
effect of Tris–HCl at wavelength lower than 200 nm. The wave-
length range was 190–250 nm. The ﬁnal spectra were the average
of three scans. The CD spectra of buffer with different concentra-
tions of AB3 were collected ﬁrst. These spectra were used as re-
ference data, and were subtracted from the spectra of rP172 ti-
trated with corresponding concentration of AB3. Finally, the CD
spectra of rP172 in the presence of AB3 were collected and re-
corded. The experiments were carried out at room temperature.3. Results
3.1. Identifying ameloblastin domains that interact with full-length
amelogenin
In order to identify the Amel-interacting domains on Ambn,
recombinant porcine Amel rP172 (which is an 89% analogue to
mouse Amel) was titrated with peptides AB1, AB3 and AB6 at pH
7.3 5 mM Tris–HCl buffer (Fig. 1(a)). CD analysis conﬁrmed that the
secondary structures of AB3 are similar to those of the wild type
sequence (AB2), suggesting that substitution of the two trypto-
phan residues did not affect folding (Fig. S1). Thus, AB3 was used
instead of the wild type sequence of Abmn (AB2) which preserves
two tryptophan residues (Table 2). When rP172 was titrated with
the AB1 comprising the N-terminal 40 amino acid residues of
Table 2
The amino acid sequences and masses for ameloblastin (AB1, AB2, AB3, and AB6) and amelogenin (TRAP) peptides. AB3 is a silenced variant of AB2 in the ﬂuorescence
studies.
Peptides Sequence Mass/Da
AB1 1VPAFPQQPGAQGMAPPGMASLSLETMRQLGSLQGLNALSQ40 4080.75
AB2 41YSRLGFGKALNSLWLHGLLPPHNSFPWIGPREHETQQ77 4284.89
AB3 41YSRLGFGKALNSLYLHGLLPPHNSFPYIGPREHETQQ77 4238.82
AB6 214YGTLFPRFGGFRQTLRRLNQNSPKGGDFTVEVDSPVSVTKGPEK257 4884.53
TRAP 1MPLPPHPGHPGYINFSYEVLTPLKWYQNMIRHPYTSYGYEPMGGW45 5324.1
Fig. 1. a. A cartoon showing locations of ameloblastin derived peptides AB1 , AB2 (or AB3) and AB6 in the full-length sequence. Fluorescence spectra of 10 μM of rP172
titrated with different concentrations of peptides b. AB1; c. AB3; d. AB6.
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of Ambn, the emission maximum wavelength (λmax) of rP172
changed only slightly (Fig. 1b and d). However, as the concentra-
tion of AB3 increased from 0 mM to 15 mM, the λmax of amelogenin
full-length spectra shifted from 339.770.58 to 342.370.58 nm
(Fig. 1(c)). This redshift suggests that the microenvironments of
the tryptophan residues of Amel become more hydrophilic in the
presence of AB3[23], and that AB3, the segment within N-terminus
encoded by exon 5, interacts with Amel. This is also supported by
observations of CD spectra of Amel in the presence of Ambn
peptides after subtraction of the peptides contribution. It was
observed that AB3 induced a change in Amel secondary structure
(Fig. 2). As the concentration of AB3 increased from 0 μM to
3.75 μM, θ222 decreased from 21,872 deg cm2 dmol1 to 
29,155 deg cm2 dmol1, and λmax shifted from 205.9 nm to
211.7 nm (Fig. 2). Analysis of the percentage of secondary struc-
tures in amelogenin using the SELCON3 algorithm showed that thepercentage of α-helix increased in the presence of AB3
(Table 3) [24]. Interestingly, the CD spectra of Amel in the presence
of the 1–40 N-terminal peptide AB1 showed no signiﬁcant changes
in amelogenin secondary structures (Fig. S2).
These observations suggest that Amel interacts with the amino
acid sequence encoded by exon 5 of Ambn (namely: AB3), and not
the N- or C-terminus.
3.2. Identifying amelogenin domains that interact with ameloblastin
peptide AB3
In order to identify the AB3 peptide interacting domains on
Amel, three amelogenin variants were created, having only one
Trp each, at positions 25, 45 and 161 (Table 1). These amelogenin
variants, rP172(W25), rP172(W45) and rP172(W161), were each
titrated by AB3. The λmax of each Trp variant was followed sepa-
rately. In dynamic light scattering (DLS) studies, we have
J. Su et al. / Biochemistry and Biophysics Reports 7 (2016) 26–32 29demonstrated that these Trp variants have similar self-assembly
behavior to the wild type rP172 at both pH 5.5 (forming oligomers)
and pH 8.0 (forming nanospheres) [21]. Further, circular dichroism
studies of the variants in their monomeric forms have conﬁrmed
that their secondary structures are highly comparable to that of
their wild-type counterpart [25]. Thus, these variants should be
structurally and functionally similar to the wild type rP172. The
Trp variants were titrated with AB3 and the λmax representing one
Trp at a time were recorded. The results show that rP172(W25)
(representing the N-terminal Trp at position 25) exhibited a sig-
niﬁcant redshift from 33170.58 to 34670 nm when the con-
centration of AB3 increased from 0 mM to 15 mM (Fig. 3(a)), while
the λmax of rP172(W45) (representing Trp at position 45) and that
of rP172(W161) (representing the C-terminal Trp) did not change
signiﬁcantly (Fig. 3b-c). The plot of λmax versus the contraction of
AB3 peptide shows these trends more clearly (Fig. 3(d)). The
redshift of rP172(W25) suggests that the microenvironment
around Trp 25 became more hydrophilic in the presence of AB3,
while that around the Trp 45 and Trp 161 did not change sig-
niﬁcantly. These observations suggest that Amel interacts with
AB3 via its N-terminal domain around Trp 25.
3.3. The interaction between TRAP and AB3
In a separate experiment, the Amel-derived peptide TRAP,
containing Trp 25 and Trp 45, was titrated with AB3. When the
concentration of AB3 increased from 0 mM to 10 mM, a redshift was
observed from 335.370.58 to 342.373.1 nm (Fig. 4(a)). Note that
the signal to noise drops low for the 5 and 10 μM additions of AB3
to TRAP. It is possible that TRAP-AB3 complexes start to aggregate
at higher concentrations of AB3 decreasing the TRAP concentra-
tion in solution. The plot of λmax versus the concentration of TRAP
makes the trend more clear, even though the error is large (Fig. 4
(b)). Consistent with the results of double variant rP172(W25), theFig. 2. CD spectra of 2.5 μM rP172 titrated with 0, 5, 10, or 15 μM AB3.
Table 3
The secondary structure content of amelogenin in the presence of AB3 as analyzed by S
AB3 [μM] Helix 1 Helix 2 Total Helix Strand 1 Str
0 0.071 0.14 0.211 0.172 0.0
5 0.084 0.095 0.179 0.07 0.0
10 0.09 0.143 0.233 0.088 0.0
15 0.209 0.136 0.345 0.043 0.0microenvironment of the tryptophan residues of TRAP became
more hydrophilic.4. Discussion
Recent in vivo and in vitro studies provide supporting evidence
that extracellular matrix protein-protein interactions may play
crucial roles in the process of crystal nucleation, growth and en-
amel tissue organization [12,14,16,17,26–28]. By in vivo co-locali-
zation and in vitro biophysical approaches, we have supported the
idea that amelogenin forms a complex with enamelin or amelo-
blastin at the mineralization front during the secretory stage of
enamel development, implying that such intermolecular com-
plexes may function to initiate mineral formation [16,27–29]. Re-
cent in situ quantitative co-localization and FRET analysis in our
laboratory revealed that the N-terminal proteolytic product of
ameloblastin co-localized with amelogenin around the prism
boundary [17]. Here, in order to support mechanisms of protein-
protein interactions in enamel formation and to better identify the
interaction domains on both amelogenin and ameloblastin, the in
vitro interactions between ameloblastin peptides and full-length
recombinant amelogenins were studied.
Fluorescence spectra of the wild type amelogenin titrated with
the ameloblastin AB3 (Y41-Q77) showed a redshift, while no shifts
were observed with AB1 (V1-Q40) and AB6 (Y214-K256). These
data suggest that AB1, encoded by exon 3 and exon 4, does not
interact with amelogenin, while AB3, encoded by exon 5 (close to
the N-terminus of ameloblastin) does interact with amelogenin.
AB6, encoded by exon 13 (at the C-terminus of ameloblastin), does
not interact with amelogenin. The redshift (from 339.770.58 to
342.370.58 nm) in the case of AB3 suggests that the tryptophan
amino residues of amelogenin are more exposed to water or the
charged residues of AB3 in the presence of AB3. Because amelo-
genin self-assembles at pH 7.3, the redshift implies that AB3 in-
teraction may dissociate the amelogenin nanospheres to oligomers
leading to exposure of the Trp residues. We have reported similar
effects of enamelin on rP172 and rP148 amelogenin leading to
their dis-assembly into oligomers. These studies may suggest that
oligomeric forms of amelogenin together with ameloblastin and
enamelin proteolytic products may well be in vivo functional en-
tities [21,29].
Note that all Trp residues (W25, W45, W161) contribute to the
intrinsic ﬂuorescence spectra of wild-type amelogenin in Fig. 1.
The use of variants with two Tyr-for-Trp substitutions allowed us
to distinguish the contribution of each Trp residue to the spectra
as the result of their interactions with ameloblastin peptide AB3.
Comparing the ﬂuorescence spectra of amelogenin variants rP172
(W25), rP172(W45) and rP172(W161) titrated with the AB3 con-
ﬁrms that the sequence around W25 is the domain for the inter-
action between amelogenin and ameloblastin AB3 peptide.
The ﬂuorescence spectra of TRAP, containing both W25 and
W45, titrated with AB3 conﬁrmed that the ameloblastin domain
encoded by exon 5 interacts with the N-terminus of amelogenin. It
is therefore reasonable to assume that the contribution of intrinsicELCON3 algorithm and based on the CD results.
and 2 Total Sheet Turns Unordered Total structure
71 0.243 0.194 0.375 1.023
33 0.103 0.11 0.655 1.046
39 0.127 0.15 0.512 1.021
69 0.112 0.236 0.318 1.011
Fig. 3. a-c. Fluorescence spectra of rP172 variants titrated with 0, 5, 10, or 15 μM of variant peptide AB3: a. 10 μM rP172(W25). b. 10 μM rP172(W45). c.10 μM rP172(W161). d.
Fluorescence shifts (λmax: the emission maximum wavelength) of rP172 variants (rP172(W25), rP172(W45), rP172(W161) as the function of AB3 concentration, titrated with
0, 5, 10, or 15 μM AB3 variant.
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at the C-terminus of TRAP and is known to be a photolytic cleavage
site [18]. TRAP is a proteolytic product of full-length amelogenin
that accumulates in the extracellular matrix during the transition
and early maturation stages [18]. The interactions demonstrated
here between TRAP and AB3 may have physiological signiﬁcance,
as suggested by others, in causing amelogenesis imperfecta [30].
As both amelogenin and ameloblastin proteins are degraded in
the progress of enamel maturation, we then hypothesized that the
interactions between proteolytic products of amelogenin (mainly
TRAP) and ameloblastin may provide the matrix that functions to
stabilize the prism organization during the early stage of enamel
maturation [17,31,32]. These results are consistent with our very
recent report that amelogenin co-localized with the N-terminal
proteolytic product of ameloblastin; FRET analysis showed that
these two peptides are in close proximity to each other [17]. The
N-terminus of amelogenin is highly conserved among species in-
dicating that domains within this segment are critical for amelo-
genin function [33]. Further evidence to support this claim is
based on the amelogenesis imperfecta cases in which mutations on
the N-terminal sequence were reported [5,34–36].
Not only amelogenin, but also ameloblastin degrades rapidly
after secretion in such a manner that the C-terminal fragments
leave the enamel, while the N-terminal fragments containing the
exon 5 coded peptide stay in the sheath space between enamel
rods [31,32,37]. Biochemical and biophysical studies suggest that
this N-terminal segment, particularly the sequence encoded by
exon 5, is involved in the self-assembly of ameloblastin [11]. Ourresults further suggest that the same segment may also be re-
sponsible for the interaction between ameloblastin and
amelogenin.
The propensity of these extracellular matrix proteins to interact
with each other and with other targets is not surprising as both
amelogenin and ameloblastin are intrinsically disordered pro-
teins [38–40]. Peptide AB3 has a relatively well deﬁned structure
in the middle, while both its N- and C-termini remain un-
structured [11,41]. It is interesting that the percentage of dis-
ordered structure in amelogenin decreases and that of α-helix
increases in the presence of AB3, implying that these two in-
trinsically disordered proteins may interact with each other,
making them more structured in order to function in vivo. Our
recent studies also showed that both SDS and phospholipids in-
duced amelogenin to form more secondary structure [42,43]. The
disorder-order transition was suggested to be vital for the inter-
actions between amelogenin and its targets.
In summary, four peptides were designed according to the
amino acid sequence of ameloblastin, and the interaction between
these peptides and amelogenin were studied. The results suggest
that ameloblastin interacts with the N-terminus of amelogenin via
the sequence encoded by exon 5. Amelogenin becomes more
structured when interacting with this domain of ameloblastin. We
suggest that macromolecular co-assembly between amelogenin
and ameloblastin may play important roles in enamel
biomineralization.
Fig. 4. a. Fluorescence spectra of 10 μM TRAP peptide titrated with 0, 5, 10, or
15 μM of variant peptide AB3; b. Fluorescence shifts (λmax: the emission maximum
wavelength) of 10 μM TRAP titrated with 0, 1, 5, or 10 μM AB3 variant peptide.
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